运动障碍性疾病
Involuntary movement disorders.
作者信息
Still C N
出版信息
Neurol Clin. 1984 Feb;2(1):71-89.
PMID:6239089
Abstract
Excluding surgical procedures, this article focuses on clinical pharmacotherapeutic approaches to treatment of parkinsonism and tremor, chorea, dystonia, tic, and tardive dyskinesia.
摘要
排除外科手术，本文重点关注帕金森症、震颤、舞蹈症、肌张力障碍、抽搐和迟发性运动障碍的临床药物治疗方法。
相似文献
1
Involuntary movement disorders.运动障碍性疾病
Neurol Clin. 1984 Feb;2(1):71-89.
2
Therapeutics of disordered movement.运动障碍的治疗学
Am Fam Physician. 1977 Sep;16(3):145-54.
3
The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).异常不自主运动障碍（运动障碍）的神经药理学
Mod Trends Neurol. 1975;6:141-66.
4
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)].[溴隐亭的神经学适应症（除帕金森病外）]
LARC Med. 1984 Feb;4(2):107-11.
5
[Therapeutic use of tiapride in movement disorders].[舒必利在运动障碍中的治疗应用]
Sem Hop. 1978 May;54(13-16):517-20.
6
The pharmacology of extrapyramidal movement disorders.锥体外系运动障碍的药理学
Monogr Neural Sci. 1973;2:1-136.
7
The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.迟发性运动障碍、自发性运动障碍及其他肌张力障碍的神经药理学
J Clin Psychopharmacol. 1982 Oct;2(5):321-8.
8
Drug treatment of diseases characterized by abnormal movements.以异常运动为特征的疾病的药物治疗。
Proc R Soc Med. 1973 Sep;66(9):871-3. doi: 10.1177/003591577306600920.
9
Catecholamines and neurologic diseases (second of two parts).儿茶酚胺与神经系统疾病（两部分中的第二部分）
N Engl J Med. 1975 Aug 14;293(7):332-8. doi: 10.1056/NEJM197508142930705.
10
[The use of levodopa in diseases other than Parkinsonism].[左旋多巴在帕金森病以外疾病中的应用]
Union Med Can. 1972 May;101(5):849-52.
引用本文的文献
1
New onset choreiform disorder in an adult with recent group A beta haemolytic streptococcal pharyngitis.一名近期患有A组β溶血性链球菌咽炎的成年人出现新发舞蹈症样障碍。
J Neurol Neurosurg Psychiatry. 1988 Mar;51(3):448-9. doi: 10.1136/jnnp.51.3.448.
Zotero 插件